Jodi Barrientos
CEO
Ribbon Bio
Ribbon Biolabs utilizes algorithm-driven technology to synthesize pristine synthetic DNA molecules, producing linear DNA up to 12 kb and plasmids up to 20 kb with high accuracy and complexity. This addresses the critical demand for longer and more complex synthetic DNA that existing technologies fail to deliver, enabling advancements in various sectors of synthetic biology.
- Artificial Intelligence
- Biotechnology
Updated 7 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Problem
Existing technologies struggle to produce long, complex synthetic DNA molecules with the high accuracy required for advanced synthetic biology applications. This limitation hinders progress in sectors requiring precise and intricate DNA constructs.
Solution
Ribbon Biolabs utilizes algorithm-driven technology to synthesize high-quality synthetic DNA molecules, offering linear DNA up to 12 kb and plasmids up to 20 kb. Their synthesis methods ensure the delivery of molecules with a broad range of complexity parameters including GC content, homopolymers, and repeats, regardless of the length of molecule. The resulting molecules are scarless, adapter-free, and ready for use in downstream applications without further manipulation. This enables partners to deliver a new generation of transformative solutions.
Target Audience
The primary customers are researchers and companies in the synthetic biology market requiring long, complex, and highly accurate synthetic DNA molecules.
Features
- Algorithm-driven technology for synthesizing pristine synthetic DNA molecules.
- Production of linear DNA up to 12 kb and plasmids up to 20 kb.
- Synthesis methods accommodate a broad range of complexity parameters, including varied GC content, homopolymers, and repeats.
- Scarless and adapter-free molecules, ready for downstream applications.